Investigator's Brochure (IB) Table

Drugs

Drug Name Sort ascending Drug Company IB Date Risk List Available?
Vorinostat (Zolinza) Merck August 2013
Tenofovir Vaginal Ring CONRAD August 2017
Tenofovir Gel CONRAD January 2013
Tenofovir Alafenamide/Elvitegravir CONRAD July 2019
Sofosbuvir/Velapatasvir (Epclusa) Gilead July 2016
Rilpivirine (TMC278, Edurant) Janssen Research & Development July 2019
Rifapentine Sanofi August 2013
Raltegravir (Isentress) Merck September 2017 YES
PC-1005 Population Council April 2017
Maraviroc (UK-427857) ViiV Healthcare October 2017
GSK1265744 (Cabotegravir) ViiV Healthcare December 2019
Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) AbbVie December 2018
Etravirine (TMC125, Intelence) Janssen Research & Development November 2019
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences December 2016 YES
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) Merck January 2020
Doravirine (MK-1439) Merck January 2020
Dolutegravir (GSK1349572) ViiV Healthcare November 2019
Delamanid (OPC-67683) Otsuka April 2019
Dapivirine (Vaginal Ring) International Partnership For Microbicides November 2019
Dapivirine (Microbicide Gel) International Partnership for Microbicides May 2017

Vaccines

Vaccine Name Vaccine Company IB Date Risk List Available?
RV460 (ALF43) - New DAIDS/NIAID/NIH February 2020
N-803 - New Altor BioScience April 2019
Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) Dynavax Technologies Corporation August 2019
PGT121.414.LS (VRC-HIVMAB0107-00-AB) VCMP/NIAID/NIH October 2019
BG505 SOSIP.664 gp140 DAIDS/NIAID/NIH October 2019
MPER-656 Liposomes with Aluminum Hydroxide Suspension DAIDS/NIAID/NIH February 2019
PGDM1400 Beth Israel Deaconess Medical Center August 2018
PGT121 Beth Israel Deaconess Medical Center January 2019
RSV 6120/DeltaNS2/1030s LID/NIAID/NIH March 2019
CH505TF gp120 Transient DAIDS/NIAID/NIH December 2018
GEO-D02 and MVA-HIV62B Vaccine GeoVax June 2019
SAR441236 Sanofi June 2018
10-1074 Rockefeller University/Mass Biologics September 2019
PDPHV-201401 Laboratory of Nucleic Acid Vaccines (LNAV) October 2017
ALVAC-HIV (vCP2438) Sanofi Pasteur August 2017
AIDSVAX B/E Global Solutions for Infectious Diseases March 2016
Ad26.ENVA.01 Crucell Holland BV June 2013
Recombinant oligomeric gp145 C.6980 Clade C HIV Env protein NIH/NIAID August 2017
RSV 276 LID/NIAID/NIH February 2019
Bivalent Subtype C gp120 with Aluminum Hydroxide Adjuvant NIAID/NIH June 2015